The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Cytotoxicity and slow release of the anti-cancer drug doxorubicin from ZIF-8
Open accessAbstract
Metal–organic frameworks are emerging as a powerful platform for the delivery and controlled release of several drug molecules. Herein, we report the incorporation of the anti-cancer drug doxorubicin into the zeolitic imidazolate framework (ZIF-8) with high-load and progressive release. Adsorption measurements show that doxorubicin is incorporated into ZIF-8 with a load of 0.049 g doxorubicin g−1 dehydrated ZIF-8. Doxorubicin is released in a highly controlled and progressive fashion with 66% of the drug released after 30 days. We also characterize the antitumoral potential and cytotoxicity of the doxorubicin-ZIF-8 (DOXO-ZIF-8) complex towards the mucoepidermoid carcinoma of human lung (NCI-H292), human colorectal adenocarcinoma (HT-29), and human promyelocytic leukemia (HL-60) cell lines. It is shown that the complex doxorubicin-ZIF-8 exhibits lower cytotoxicity than pure doxorubicin for the tested cells, possibly due to the slower release of the incorporated drug. Furthermore, host–guest interactions have been addressed from a microscopic perspective through molecular docking simulations. In conjunction with our experimental characterization, the calculations suggest that doxorubicin binds preferentially to the surface rather than into the pores of ZIF-8, whose entry diameter is at least half the size of the shortest axis of the drug. These findings are also consistent with high-resolution X-ray crystallography and NMR spectroscopy studies of ZIF-8 which shows that this framework is very rigid under constant pressure in contrast to previous experimental and theoretical studies of ZIF-8 under gas pressure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21256 · Cited by 25,486
A profile refinement method for nuclear and magnetic structures
Rietveld, H. M. (1969) · Journal of Applied Crystallography · doi:10.1107/s0021889869006558 · Cited by 17,524
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1107 · Cited by 9,766
EXPGUI, a graphical user interface for GSAS
Toby, B. H. (2001) · Journal of Applied Crystallography · doi:10.1107/s0021889801002242 · Cited by 9,247
Reticular synthesis and the design of new materials
Yaghi, O. M., O'Keeffe, M., Ockwig, N. W., Chae, H. K., Eddaoudi, M., & Kim, J. (2003) · Nature · doi:10.1038/nature01650 · Cited by 9,101
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Design and synthesis of an exceptionally stable and highly porous metal-organic framework
Li, H., Eddaoudi, M., O'Keeffe, M., & Yaghi, O. M. (1999) · Nature · doi:10.1038/46248 · Cited by 8,554
Exceptional chemical and thermal stability of zeolitic imidazolate frameworks
Park, K. S., Ni, Z., Côté, A. P., Choi, J. Y., Huang, R., Uribe-Romo, F. J., Chae, H. K., O’Keeffe, M., & Yaghi, O. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602439103 · Cited by 7,563
NWChem: A comprehensive and scalable open-source solution for large scale molecular simulations
Valiev, M., Bylaska, E. J., Govind, N., Kowalski, K., Straatsma, T. P., Van Dam, H. J. J., Wang, D., Nieplocha, J., Apra, E., Windus, T. L., et al. (2010) · Computer Physics Communications · doi:10.1016/j.cpc.2010.04.018 · Cited by 5,779
Eddaoudi, M., Moler, D. B., Li, H., Chen, B., Reineke, T. M., O'Keeffe, M., & Yaghi, O. M. (2001) · Accounts of Chemical Research · doi:10.1021/ar000034b · Cited by 5,180
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Horcajada, P., Chalati, T., Serre, C., Gillet, B., Sebrie, C., Baati, T., Eubank, J. F., Heurtaux, D., Clayette, P., Kreuz, C., et al. (2010) · Nature Materials · doi:10.1038/nmat2608 · Cited by 4,260
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
James, S. L. (2003) · Chemical Society Reviews · doi:10.1039/b200393g · Cited by 3,580
Engineering Metal Organic Frameworks for Heterogeneous Catalysis
Corma, A., García, H., & Llabrés i Xamena, F. X. (2010) · Chemical Reviews · doi:10.1021/cr9003924 · Cited by 3,478
Rietveld refinement of Debye–Scherrer synchrotron X-ray data from Al2O3
Thompson, P., Cox, D. E., & Hastings, J. B. (1987) · Journal of Applied Crystallography · doi:10.1107/s0021889887087090 · Cited by 2,820
Goodford, P. J. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00145a002 · Cited by 2,634
Secondary building units, nets and bonding in the chemistry of metal–organic frameworks
Tranchemontagne, D. J., Mendoza-Cortés, J. L., O’Keeffe, M., & Yaghi, O. M. (2009) · Chemical Society Reviews · doi:10.1039/b817735j · Cited by 2,478
A semiempirical free energy force field with charge‐based desolvation
Huey, R., Morris, G. M., Olson, A. J., & Goodsell, D. S. (2007) · Journal of Computational Chemistry · doi:10.1002/jcc.20634 · Cited by 2,246
Metal–Organic Frameworks as Efficient Materials for Drug Delivery
Horcajada, P., Serre, C., Vallet‐Regí, M., Sebban, M., Taulelle, F., & Férey, G. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200601878 · Cited by 2,024
Metal–Organic Frameworks: Opportunities for Catalysis
Farrusseng, D., Aguado, S., & Pinel, C. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200806063 · Cited by 1,888
Metal-Organic Framework as a Template for Porous Carbon Synthesis
Liu, B., Shioyama, H., Akita, T., & Xu, Q. (2008) · Journal of the American Chemical Society · doi:10.1021/ja7106146 · Cited by 1,829
Huang, X., Lin, Y., Zhang, J., & Chen, X. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200503778 · Cited by 1,816
Flexible Porous Metal-Organic Frameworks for a Controlled Drug Delivery
Horcajada, P., Serre, C., Maurin, G., Ramsahye, N. A., Balas, F., Vallet-Regí, M., Sebban, M., Taulelle, F., & Férey, G. (2008) · Journal of the American Chemical Society · doi:10.1021/ja710973k · Cited by 1,794
Powder pattern indexing with the dichotomy method
Boultif, A., & Louër, D. (2004) · Journal of Applied Crystallography · doi:10.1107/s0021889804014876 · Cited by 1,459
BioMOFs: Metal–Organic Frameworks for Biological and Medical Applications
McKinlay, A. C., Morris, R. E., Horcajada, P., Férey, G., Gref, R., Couvreur, P., & Serre, C. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000048 · Cited by 1,256
Opening the Gate: Framework Flexibility in ZIF-8 Explored by Experiments and Simulations
Fairen-Jimenez, D., Moggach, S. A., Wharmby, M. T., Wright, P. A., Parsons, S., & Düren, T. (2011) · Journal of the American Chemical Society · doi:10.1021/ja202154j · Cited by 1,211
Highly Porous and Stable Metal−Organic Frameworks: Structure Design and Sorption Properties
Eddaoudi, M., Li, H., & Yaghi, O. M. (2000) · Journal of the American Chemical Society · doi:10.1021/ja9933386 · Cited by 1,091
Metal–organic frameworks as potential drug carriers
Huxford, R. C., Della Rocca, J., & Lin, W. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.12.012 · Cited by 840
Biomedical Applications of Metal Organic Frameworks
Keskin, S., & Kızılel, S. (2011) · Industrial & Engineering Chemistry Research · doi:10.1021/ie101312k · Cited by 607
A Catalytically Active, Permanently Microporous MOF with Metalloporphyrin Struts
Shultz, A. M., Farha, O. K., Hupp, J. T., & Nguyen, S. T. (2009) · Journal of the American Chemical Society · doi:10.1021/ja900203f · Cited by 546
Nelson, A. P., Farha, O. K., Mulfort, K. L., & Hupp, J. T. (2009) · Journal of the American Chemical Society · doi:10.1021/ja808853q · Cited by 539
Application of symmetrized harmonics expansion to correction of the preferred orientation effect
Järvinen, M. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889893001219 · Cited by 424
Farha, O. K., Malliakas, C. D., Kanatzidis, M. G., & Hupp, J. T. (2010) · Journal of the American Chemical Society · doi:10.1021/ja909519e · Cited by 363
Heath, J. R., & Davis, M. E. (2008) · Annual Review of Medicine · doi:10.1146/annurev.med.59.061506.185523 · Cited by 354
Metal–organic framework structures – how closely are they related to classical inorganic structures?
Natarajan, S., & Mahata, P. (2009) · Chemical Society Reviews · doi:10.1039/b815106g · Cited by 318
Lewis, D. W., Ruiz-Salvador, A. R., Gómez, A., Rodriguez-Albelo, L. M., Coudert, F.-X., Slater, B., Cheetham, A. K., & Mellot-Draznieks, C. (2009) · CrystEngComm · doi:10.1039/b912997a · Cited by 246
An Interpenetrated Framework Material with Hysteretic CO2 Uptake
Mulfort, K. L., Farha, O. K., Malliakas, C. D., Kanatzidis, M. G., & Hupp, J. T. (2010) · Chemistry – A European Journal · doi:10.1002/chem.200902104 · Cited by 200
Dai, X., Yue, Z., Eccleston, M., Swartling, J., Slater, N. K. H., & Kaminski, C. F. (2008) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2007.12.002 · Cited by 147
Real time in vitro studies of doxorubicin release from PHEMA nanoparticles
Chouhan, R., & Bajpai, A. (2009) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-7-5 · Cited by 116
Engineered Nanocarriers of Doxorubicin: A Current Update
Patil, R., Guhagarkar, S. A., & Devarajan, P. V. (2008) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v25.i1.10 · Cited by 94
Cited by
Zheng, H., Zhang, Y., Liu, L., Wan, W., Guo, P., Nyström, A. M., & Zou, X. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b11720 · Cited by 1,383
Zeolitic imidazolate framework materials: recent progress in synthesis and applications
Chen, B., Yang, Z., Zhu, Y., & Xia, Y. (2014) · J. Mater. Chem. A · doi:10.1039/c4ta02984d · Cited by 1,009
He, C., Liu, D., & Lin, W. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00125 · Cited by 1,001
Metal–Organic Frameworks for Drug Delivery: A Design Perspective
Lawson, H. D., Walton, S. P., & Chan, C. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c01089 · Cited by 916
Characterization and properties of Zn/Co zeolitic imidazolate frameworks vs. ZIF-8 and ZIF-67
Zhou, K., Mousavi, B., Luo, Z., Phatanasri, S., Chaemchuen, S., & Verpoort, F. (2017) · Journal of Materials Chemistry A · doi:10.1039/c6ta07860e · Cited by 778
Metadata
- Authors
- Vasconcelos, I. B., Silva, T. G. D., Militão, G. C. G., Soares, T. A., Rodrigues, N. M., Rodrigues, M. O., Costa, N. B. D., Freire, R. O., & Junior, S. A.
- Venue
- RSC Advances
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2012
- Volume
- 2
- Issue
- 25
- Pages
- 9437
- ISSN
- 2046-2069 (ISSN-L)
- OpenAlex
- W1998358059
- Cited by
- 311
- References
- 42
- FWCI
- 5.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.